GENZYME CORP Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
GENZYME CORP had Deferred Tax Assets, Net of Valuation Allowance, Noncurrent of $369.63 million as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetNoncurrent · last filed 2011-03-01
- 2010-12-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $369.63M.
- 2010-09-30: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $590.76M.
- 2010-06-30: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $522.31M.
- 2010-03-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $401.37M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent |
|---|---|
| 2010-12-31 | $369.63M 10-K · filed 2011-03-01 |
| 2010-09-30 | $590.76M 10-Q · filed 2010-11-09 |
| 2010-06-30 | $522.31M 10-Q/A · filed 2010-09-07 |
| 2010-03-31 | $401.37M 10-Q/A · filed 2010-05-11 |
| 2009-12-31 | $376.81M 10-K · filed 2011-03-01 |
| 2009-09-30 | $386.14M 10-Q · filed 2009-11-02 |
| 2009-06-30 | $362.04M 10-Q/A · filed 2009-09-04 |
| 2008-12-31 | $269.24M 8-K · filed 2010-06-14 |